Table 3.
Oral treatment (n = 8) | Cholesterol (mg %) | HDL-CH (mg %) | VLDL-CH (mg %) | LDL-CH (mg %) | Triglyceride (mg %) | Blood glucose (mg %) |
Mean ± SEM | ||||||
Normal control | 80.8 ± 1.7 | 18.7 ± 0.9 | 8.4 ± 0. | 54.4 ± 0.21 | 60.4 ± 0.39 | 68.8 ± 2.1 |
Obese control | 115.9 ± 2.7b | 27.8 ± 0.4a | 24.6 ± 0.8b | 64.4 ± 2.2a | 123.2 ± 4.1b | 116.5 ± 1.6b |
MCE (150 mg/kg) | 88.5 ± 1.7c | 31.2 ± 0.6c | 20.2 ± 0.9c | 37.2 ± 2.0d | 100.9 ± 4.4c | 94.5 ± 1.1a |
MCE (300 mg/kg) | 81.6 ± 1.9d | 32.4 ± 0.6d | 17.8 ± 0.2d | 26.3 ± 3.1d | 88.7 ± 3.2d | 77.1 ± 1.2d |
Significant difference of Obese control from Normal control: aP < 0.05, bP < 0.01,
Significant difference of treatment groups from Obese control: cP < 0.01, dP < 0.001